China’s medical technology company Genskey raised hundreds of millions of yuan in a series B round funding by Softbank China, Lingang LC Investment, and Juyuan Capital. Use of the investment was undisclosed.
Established in 2017, Gneskey focuses on R&D of infection diagnosis products and medical assessment of infection diseases. It have served hundreds of hospitals and over 1000 doctors.
South Africa Today